Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Spondyloarthritis in over 16s: diagnosis and management

NICE guideline
Reference number: NG65
Published: 28 February 2017
Last updated: 02 June 2017

History

Committee list updated

Committee member list & DOIs (PDF 328 KB)

Published:

28 February 2017

Stakeholder list updated

Stakeholder list (PDF 249 KB)

Published:

28 February 2017

Consultation comments published

Consultation comments and responses (PDF 1.29 MB)

Published:

28 February 2017

Equality and health inequalities assessment

Equality impact assessment Section 4 (PDF 140 KB)

Published:

25 January 2017

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 1.98 MB)

Published:

13 September 2016
Short version of draft guideline (PDF 490 KB)

Published:

13 September 2016
Comments form (MSWord 61 KB)

Published:

13 September 2016
Equality impact assessment - Section 3 (PDF 76 KB)

Published:

13 September 2016
Guideline appendix A - Committee & DOI (PDF 306 KB)

Published:

13 September 2016
Guideline appendix B - Guideline scope (PDF 165 KB)

Published:

13 September 2016
Guideline appendix C - Review protocol (PDF 640 KB)

Published:

13 September 2016
Guideline appendix D - Search strategies (PDF 364 KB)

Published:

13 September 2016
Guideline appendix E - Evidence tables (PDF 6.24 MB)

Published:

13 September 2016
Guideline appendix F - Excluded studies (PDF 1.74 MB)

Published:

13 September 2016
Guideline appendix G - GRADE tables and meta-analysis results (PDF 12.73 MB)

Published:

13 September 2016
Guideline appendix H - Health Economics report (PDF 1.42 MB)

Published:

13 September 2016
Guideline appendix I - Expert witness RQ18 (PDF 147 KB)

Published:

13 September 2016
Guideline appendix J - TSU report on pain NMA (PDF 911 KB)

Published:

13 September 2016

Pre-consultation documents released

Search strategies (MSWord 85 KB)

Published:

03 August 2016
Review questions (MSWord 24 KB)

Published:

03 August 2016
Economic plan (MSWord 34 KB)

Published:

03 August 2016

Committee meetings

Committee meeting
Minutes - Meeting 2 (PDF 222 KB)

Published:

27 October 2014
Minutes - Meeting 1 (PDF 204 KB)

Published:

15 September 2014
Minutes - Meeting 3 (PDF 126 KB)

Published:

16 December 2014
Minutes - Meeting 4 (PDF 124 KB)

Published:

10 February 2015
Minutes - Meeting 5 (PDF 245 KB)

Published:

24 March 2015
Minutes - Meeting 6 (PDF 328 KB)

Published:

15 June 2015
Minutes - Meeting 7 (PDF 238 KB)

Published:

29 July 2015
Minutes - Meeting 8 (PDF 370 KB)

Published:

07 September 2015
Minutes - Meeting 9 (PDF 243 KB)

Published:

27 October 2015
Minutes - Meeting 10 (PDF 288 KB)

Published:

24 November 2015
Minutes - Meeting 11 (PDF 211 KB)

Published:

11 January 2016
Minutes - Meeting 12 (PDF 180 KB)

Published:

02 March 2016
Minutes - Meeting 13 (PDF 261 KB)

Published:

19 April 2016
Minutes Post-consultation meeting (PDF 379 KB)

Published:

29 November 2016

GDG membership

GDG membership
GDG membership (PDF 15 KB)

Published:

12 September 2014

Seronegative arthropathies: scope consultation

Seronegative arthropathies: scope consultation information
Scoping equality impact assessment
Scoping equality impact assessment (PDF 226 KB)

Published:

12 September 2014
Scope consultation comments table
Scope consultation comments table (PDF 271 KB)

Published:

12 September 2014
Final scope
Final scope (PDF 204 KB)

Published:

12 September 2014
Seronegative arthropathies: draft scope
Seronegative arthropathies: draft scope (PDF 132 KB)

Published:

20 May 2014
Seronegative arthropathies: scoping workshop notes information
Seronegative arthropathies: scoping workshop notes (PDF 166 KB)

Published:

20 May 2014

Seronegative arthropathies: list of registered stakeholders

Seronegative arthropathies: list of registered stakeholders
Seronegative arthropathies: list of registered stakeholders (PDF 23 KB)

Published:

05 June 2015